missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ MAL Monoclonal Antibody (B5-G3)
Description
MAL Monoclonal Antibody for Flow, IHC (P), Western Blot
MAL, a nonglycosylated integral membrane proteolipid, has been identified as a major internal component of glycolipid-enriched membrane (GEM) microdomains. MAL is the first integral membrane proteolipid component to have been shown as a necessary element in the cellular apical sorting apparatus for newly synthesized proteins. In its steady state this highly hydrophobic proteolipid, resides predominantly in the apical zone of polarized epithelial cells. It has also been shown in itinerant protein cycling between the plasma membrane and endosomes and in other cells. This 17-kDa proteolipid contains four putative transmembrane domains. These domains along with its protein trafficking properties are defined by the specific signals delegated by its specific amino acid sequence.
Specifications
Specifications
| Antigen | MAL |
| Applications | Flow Cytometry, Immunohistochemistry (Paraffin), Western Blot |
| Classification | Monoclonal |
| Clone | B5-G3 |
| Concentration | 2 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.2% BSA, 50% Glycerol and 0.05% sodium azide; pH 7.4 |
| Gene | MAL |
| Gene Accession No. | O09198, P21145, Q64349 |
| Gene Alias | 17 kDa myelin vesicular protein; Mal; mal T-cell differentiation protein; mal, T cell differentiation protein L homeolog; mal, T-cell differentiation protein; mal.L; MALGENE; Mpv17; Mvp17; MyD88-adapter-like; myelin and lymphocyte protein; myelin and lymphocyte protein, T cell differentiation protein; myelin and lymphocyte protein, T-cell differentiation protein; NS 3; T-lymphocyte maturation-associated protein; Vip17; XELAEV_18026637mg |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?